GAO re­port rais­es ques­tions about reau­tho­riz­ing two PRV pro­grams

With the rare pe­di­atric dis­ease and med­ical coun­ter­mea­sure pri­or­i­ty re­view vouch­er (PRV) pro­grams set to ex­pire by 2022 and 2023, re­spec­tive­ly, the Gov­ern­ment Ac­count­abil­i­ty Of­fice …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.